Autoimmune hepatitis 2013 and beyond

Minerva Gastroenterologica e Dietologica

Volumn 59, Issue 2, 2013, Pages 133-141

  Weiler Normann, C ^a   Sebode, M ^a   Lohse, A W ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Hepatitis; Hepatitis, autoimmune; Liver diseases

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS;

AUTOIMMUNE HEPATITIS; GERIATRIC CARE; HUMAN; LIVER BIOPSY; PREGNANCY; PROGNOSIS; REMISSION; REVIEW;

ALGORITHMS; HEPATITIS, AUTOIMMUNE; HUMANS;

EID: 84884681945     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354:54-66. (Pubitemid 43048951)
2. Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol 2002;35:75-81. (Pubitemid 34663355)
3. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76. (Pubitemid 351975541)
4. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38. (Pubitemid 29514229)
5. Suzuki A, Brunt EM, Kleiner DE, Miquel R, Smyrk TC, Andrade RJ et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011;54:931-9.
6. Weiler-Normann C, Schramm C. Drug induced liver injury and its relationship to autoimmune hepatitis. J Hepatol 2011;55:747-9.
7. Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M et al. Long-term outcome of Japanese patients with type 1 autoimmune hepatitis. Hepatology 2012;56:668-76.
8. Kanzler S, Lohr H, Gerken G, Galle PR, Lohse AW. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol 2001;39:339-41, 344-338.
9. Ngu JH, Gearry RB, Frampton CM, Stedman CA. Predictors of poor outcome in patients with autoimmune hepatitis: A population-based study. Hepatology 2012 [Epub ahead of print].
10. Luth S, Herkel J, Kanzler S, Frenzel C, Galle PR, Dienes HP et al. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. J Clin Gastroenterol 2008;42:926-30.
11. Ilyas JA, O'Mahony CA, Vierling JM. Liver transplantation in autoimmune liver diseases. Best Pract Res Clin Gastroenterol 2011;25:765-82.
12. Sockalingam S, Blank D, Abdelhamid N, Abbey SE, Hirschfield GM. Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors. J Hepatol 2012;57:1299-304.
13. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971;40:159-85.
14. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193-213.
15. Schramm C, Weiler-Normann C, Wiegard C, Hellweg S, Muller SA, Lohse W. Treatment response in patients with autoimmune hepatitis. Hepatology 2010;52:2247-8.
16. Manns MP, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 2010;139:1198-206.
17. Lohse AW, Gil H. Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment. J Hepatol 2011;54:837-9.
18. Hempfling W, Grunhage F, Dilger K, Reichel C, Beuers U, Sauerbruch T. Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis. Hepatology 2003;38:196-202. (Pubitemid 36775811)
19. Mackay IR. Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone. Q J Med 1968;37:379-92.
20. de Boer NK, van Nieuwkerk CM, Aparicio Pages MN, de Boer SY, Derijks LJ, Mulder CJ. Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine. Eur J Gastroenterol Hepatol 2005;17:457-61. (Pubitemid 40477518)
21. O'Donovan P, Perrett CM, Zhang X, Montaner B, Xu YZ, Harwood CA et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005;309:1871-4. (Pubitemid 41325100)
22. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
23. Weiler-Normann C, Lohse AW. Autoimmune hepatitis: a life-long disease. J Hepatol 2013;58:5-7.
24. Zachou K, Gatselis N, Papadamou G, Rigopoulou EI, Dalekos GN. Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients. J Hepatol 2011;55:636-46.
25. Sharzehi K, Huang MA, Schreibman IR, Brown KA. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy. Can J Gastroenterol 2010;24:588-92.
26. Hennes EM, Oo YH, Schramm C, Denzer U, Buggisch P, Wiegard C et al. Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol 2008;103:3063-70.
27. van Gerven NM, Verwer BJ, Witte BI, Hoek BV, Coenraad MJ, van Erpecum KJ et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol 2013;58:141-7.
28. Cuarterolo M, Ciocca M, Velasco CC, Ramonet M, Gonzalez T, Lopez S et al. Follow-up of children with autoimmune hepatitis treated with cyclosporine. J Pediatr Gastroenterol Nutr 2006;43:635-9. (Pubitemid 44863691)
29. Larsen FS, Vainer B, Eefsen M, Bjerring PN, Adel Hansen B. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. World J Gastroenterol 2007;13:3232-6. (Pubitemid 47064587)
30. Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, Taheri H, Kamalian N, Sotoudeh M. Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 2001;46:1321-7. (Pubitemid 32523281)
31. Kerkar N, Dugan C, Rumbo C, Morotti RA, Gondolesi G, Shneider BL et al. Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplant 2005;5:1085-9. (Pubitemid 40571258)
32. Kanzler S, Gerken G, Dienes HP, Meyer zum Buschenfelde KH, Lohse AW. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis-report of three cases. Z Gastroenterol 1997;35:571-8. (Pubitemid 27321630)
33. Sultan MI, Biank VF, Telega GW. Successful treatment of autoimmune hepatitis with methotrexate. J Pediatr Gastroenterol Nutr 2011;52:492-4.
34. Barth E, Clawson J. A case of autoimmune hepatitis treated with rituximab. Case Rep Gastroenterol 2010;4:502-9.
35. Weiler-Normann C, Wiegard C, Schramm C, Lohse AW. A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade. Am J Gastroenterol 2009;104:2877-8.
36. Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N et al. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol 2013;58:529-34.
37. Patel DD, Lee DM, Kolbinger F, Antoni C. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis 2013;72(Suppl 2):iii116-iii123.
38. Knolle P, Mayet W, Lohse AW, Treichel U, Meyer zum Buschenfelde KH, Gerken G. Complete congenital heart block in autoimmune hepatitis (SLA-positive). J Hepatol 1994;21:224-6. (Pubitemid 24270549)
39. Aggarwal N, Chopra S, Suri V, Sikka P, Dhiman RK, Chawla Y. Pregnancy outcome in women with autoimmune hepatitis. Arch Gynecol Obstet 2011;284:19-23.
40. Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006;101:556-60. (Pubitemid 43340932)
41. Westbrook RH, Yeoman AD, Kriese S, Heneghan MA. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 2012;38:J239-44.
42. de Boer NK, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RAI, van Bodegraven AA. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 2006;101:1390-2. (Pubitemid 43830009)
43. Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A 2012;158A:588-96.
44. Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011;117:1499-506.
45. Schnitzler F, Fidder H, Ferrante M, Ballet V, Noman M, Van Assche G et al. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis 2011;17:1846-54.
46. Schramm C, Kanzler S, zum Buschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol 2001;96:1587-91. (Pubitemid 32455095)
47. Ngu JH, Bechly K, Chapman BA, Burt MJ, Barclay ML, Gearry RB et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol 2010;25:1681-6.